Talkspace, Inc.

NASDAQ:TALK

Medical - Care Facilities

Healthcare
$5.25 +0.19%

+$0.01 today

Market cap
$879.44M
Beta
1.07
P/E (TTM)
749.9
EPS (TTM)
$0.01
52W Low $2.22High $5.23

Volume 2.41M

Average 2.55M

TALK EBITDA Margin

EBITDA as a percentage of revenue.

Talkspace, Inc.NASDAQ: TALK

EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026

EBITDA Margin narrows to -7.5%

EBITDA Margin was -7.5% in Q1 FY2026, down 9.6 pp from a year earlier. On a trailing-twelve-month basis it was 2.6%, up 0.4 pp year over year. Over 3 fiscal years it widened by 70.2 pp.

Context

  • EBITDA Margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 2 analysts of -24.9% for the fiscal year ending Dec 2026, down from 4.9% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-7.5%-16.9 pp QoQ
Last fiscal yearDec 2025
4.9%+3.8 pp YoY
LTMMar 2026
2.6%+0.4 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-9.6 pp-25.4 pp-15.8 pp
1 year+3.8 pp-29.8 pp-33.6 pp
3 years+70.2 pp-29.8 pp-100.0 pp
5 years-29.8 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
4.9%
Year-over-year change
+3.8pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How TALK compares with its peers on the latest reported figures

  • TALK's LTM Mar 2026 EBITDA Margin of 2.6% is the 5th highest of the 10 companies compared; the peer median is 1.2%.
  • Its year-over-year change of +0.4 pp is the 8th highest of 9, against a peer median of +8.6 pp.
  • Over three fiscal years its change of +70.2 pp compares with a peer median of +2.8 pp.
TALK Competitors Peer median
EBITDA Margin for TALK and competitors
Company Period LTM level YoY 3-year change
NNNNAnbio Biotechnology Class A Ordinary SharesFY202566.7% +35.3 pp+24.1 pp
RIGLRigel Pharmaceuticals, Inc.LTM Mar 202643.8% +19.9 pp+89.5 pp
CYHCommunity Health Systems, Inc.LTM Mar 202623.1% +13.2 pp+6.6 pp
AIRSAirSculpt Technologies, Inc.LTM Mar 20262.8% +4.1 pp-1.9 pp
TALKTalkspace, Inc.LTM Mar 20262.6% +0.4 pp+70.2 pp
SNDASonida Senior Living, Inc.LTM Mar 20261.2% -11.7 pp-1.1 pp
INNVInnovAge Holding Corp.LTM Mar 20260.5% +1.0 pp-0.9 pp
AVNSAvanos Medical, Inc.LTM Mar 2026-3.0% +46.3 pp-16.1 pp
CLPTClearPoint Neuro, Inc.LTM Mar 2026-58.2% +0.7 pp+19.4 pp
KALVKalVista Pharmaceuticals, Inc.LTM Dec 2025-101.1% ——
CMPSCOMPASS Pathways plcFY2025— ——
Peer median (excluding TALK) 1.2%+8.6 pp+2.8 pp

Competitors are the stored peer set for TALK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue113.67M119.57M150.05M187.59M228.87M
Cost of Revenue46.9M59.23M75.67M101.76M130.52M
Gross Profit66.77M60.34M74.38M85.84M98.35M
Gross Margin58.7%50.5%49.6%45.8%43.0%
Research & Development15.92M21.66M17.57M10.51M9.54M
Selling, General & Admin135.41M109.11M73.86M73.28M75.57M
Operating Expenses160.7M137.36M97.59M90.33M95.2M
Depreciation & Amortization1.97M1.36M1.2M859K2.88M
EBITDA(60.72M)(78.06M)(17.77M)2.1M11.24M
EBITDA Margin-53.4%-65.3%-11.8%1.1%4.9%
Operating Income(93.92M)(77.02M)(23.21M)(4.5M)3.15M
Operating Margin-82.6%-64.4%-15.5%-2.4%1.4%
Interest Income31.23M3.74M4.25M5.74M5.22M
Interest Expense00000
Other Income / Expenses31.23M(2.39M)4.25M5.74M5.22M
Income Before Tax(62.7M)(79.42M)(18.96M)1.24M8.37M
Pre-Tax Margin-55.2%-66.4%-12.6%0.7%3.7%
Income Tax Expense47K254K218K94K574K
Net Income(62.74M)(79.67M)(19.18M)1.15M7.79M
Net Margin-55.2%-66.6%-12.8%0.6%3.4%
EPS (Basic)(0.72)(0.51)(0.12)0.010.05
EPS (Diluted)(0.72)(0.51)(0.12)0.010.04
Weighted Avg Shares154.08M156.89M165.04M168.91M168.43M
Weighted Avg Shares (Diluted)154.08M156.89M165.04M176.5M173.75M

Talkspace, Inc.

NASDAQ:TALK

Intrinsic Alpha fair value

Locked

Current Price

$5.25

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.